Hotez is calling out a real pattern: generic antiparasitic drugs (ivermectin, fenbendazole) are being heavily marketed as cancer treatments by wellness influencers through expensive telehealth visits, despite no clinical evidence supporting their use. The core facts check out — news sources confirm both the repackaging of cheap generics at markup and the lack of evidence for these drugs in cancer care. His framing is combative and makes character judgments about motivations, but the underlying business model and medical claims are substantiated.